Hem °Ë»ö°á°ú

100 °Ç (1/10 ÂÊ)
»ó¼¼Á¶°Ç    ÆÄÀÏÁ¾·ù 

ICH Case study(Intracerebral Hemorrhage, Intracranial Hemorrhage)

ICH Case study(Intracerebral Hemorrhage, Intracranial Hemorrhage)

ICH Case study(Intracerebral Hemorrhage, Intracranial Hemorrhage) / 1. ¼­·Ð 2. º»·Ð 1) ¹®Çå°íÂû 2) »ç·Ê¼Ò°³ 3) °£È£°úÁ¤ 3. °á·Ð 4. Âü°í¹®Çå / 1. ¼­·Ð Intracerebral hemorrhage (ICH) and intracranial hemorrhage (ICH) represent critical neurosurgical emergencies characterized by the accumulation of blood within the cranial cavity, which can occur due¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   6page   3,000 ¿ø
NS(½Å°æ¿Ü°ú) CASE STUDY Closed Traumatic Intracranial Hemorrhage (Subdural Hemorrhage)

NS(½Å°æ¿Ü°ú) CASE STUDY Closed Traumatic Intracranial Hemorrhage (Subdural Hemorrhage)

1. ÁÖ Áõ»ó Closed Traumatic Intracranial Hemorrhage, ƯÈ÷ Subdural HemorrhageÀÇ ÁÖ Áõ»óÀº.. / 1. ÁÖ Áõ»ó 2. ÀÔ¿øµ¿±â¿Í Çöº´·Â 3. °ú°Å·Â 4. ÀμöÀΰè 5. ½Åü»çÁ¤ 6. Áø´Ü°Ë»ç 7. ¾à¹° 8. Abnormal Data Lists 9. Data Clustering & Preliminary Diagnosis 10. Nursing Diagnosis 11. °£È£°úÁ¤ / 1. ÁÖ Áõ»ó Closed Traumatic Intracranial Hemorrhage, ƯÈ÷ Subd¡¦
¹æ¼ÛÅë½Å > ±âŸ   8page   3,000 ¿ø
¼ºÀΰ£È£ÇÐ ³úÃâÇ÷ »ç·Êº¸°í¼­ Intracerebral Hemorhage Case study

¼ºÀΰ£È£ÇÐ ³úÃâÇ÷ »ç·Êº¸°í¼­ Intracerebral Hemorhage Case study

1. ¹®Çå°íÂû Ç×ÀÀ°íÁ¦) µîµµ ³ú³»ÃâÇ÷ÀÇ ¿øÀÎÀÌ µÉ ¼ö ÀÖ´Ù. ¶ÇÇÑ, ¾ËÄÚ¿Ã ³²¿ëÀ̳ª ¿Ü»óÀÌ ÀÖÀ» °æ¿ì¿¡µµ ³ú³»ÃâÇ÷ÀÇ À§ÇèÀº Áõ°¡ÇÑ´Ù. ÀÓ»óÀû.. / 1. ¹®Çå°íÂû 2. °£È£°úÁ¤ 3. Âü°í¹®Çå / 1. ¹®Çå°íÂû Ç×ÀÀ°íÁ¦) µîµµ ³ú³»ÃâÇ÷ÀÇ ¿øÀÎÀÌ µÉ ¼ö ÀÖ´Ù. ¶ÇÇÑ, ¾ËÄÚ¿Ã ³²¿ëÀ̳ª ¿Ü»óÀÌ ÀÖÀ» °æ¿ì¿¡µµ ³ú³»ÃâÇ÷ÀÇ À§ÇèÀº Áõ°¡ÇÑ´Ù. ÀÓ»óÀû Áø´ÜÀº ÁÖ·Î CT(ÄÄÇ»ÅÍ ´ÜÃþÃÔ¿µ)³ª MRI(Àڱ⡦
¹æ¼ÛÅë½Å > °£È£Çаú   2page   3,000 ¿ø
¼ºÀΰ£È£ÇÐ ¼ö¼ú¹æ½Ç½À A£« BPHA (bipolar hemi arthroplasty)

¼ºÀΰ£È£ÇÐ ¼ö¼ú¹æ½Ç½À A£« BPHA (bipolar hemi arthroplasty)

¡¥ ¼ö¼ú Áß ÇϳªÀÎ ¾ç±Ø¼º ¹Ý°üÀý ġȯ¼ú(Bipolar Hemiarthroplasty, BPHA)Àº °í°üÀý ÁúȯÀ» °¡Áø ȯÀڵ鿡°Ô ½ÃÇàµÇ´Â ºó¹øÇÑ ¼ö¼ú Áß Çϳª·Î, ¼ºÀΰ£È£ÇÐÀÇ ½Ç¹«¿¡¼­ Áß¿äÇÑ À§Ä¡¸¦ Â÷ÁöÇÑ´Ù. BPHA´Â ÁÖ·Î °í°üÀý °ñÀýÀ̳ª ÅðÇ༺ °üÀý¿°°ú °°Àº »óÅ·ΠÀÎÇØ ³ªÅ¸³ª´Â ÅëÁõ ¹× ±â´ÉÀÇ ÀúÇϸ¦ °³¼±Çϱâ À§ÇÑ ¸ñÀûÀ» °¡Áö°í ÀÖÀ¸¸ç, À̸¦ ÅëÇØ È¯ÀÚÀÇ »îÀÇ ÁúÀ» Çâ»ó½ÃÅ°´Â °ÍÀ» ¸ñÇ¥·Î ÇÑ¡¦
¹æ¼ÛÅë½Å > °£È£Çаú   6page   3,000 ¿ø
¼ºÀΰ£È£ÇÐ A£«] ÄÉÀ̽º½ºÅ͵ð subarachnoid hemorrhageSAH(ÁöÁÖ¸·ÇÏÃâÇ÷) °£È£°úÁ¤

¼ºÀΰ£È£ÇÐ A£«] ÄÉÀ̽º½ºÅ͵ð subarachnoid hemorrhageSAH(ÁöÁÖ¸·ÇÏÃâÇ÷) °£È£°úÁ¤

¼ºÀΰ£È£ÇÐ A£«] ÄÉÀ̽º½ºÅ͵ð subarachnoid hemorrhageSAH(ÁöÁÖ¸·ÇÏÃâÇ÷) °£È£°úÁ¤ / ¥°. ¹®Çå°íÂû 1. Á¤ÀÇ 2. ¿øÀÎ 3. Áõ»ó 4. Áø´Ü°Ë»ç 5. Ä¡·á 6. °£È£ ¥±. °£È£»çÁ¤ 1. ÀϹÝÀû Ư¼º 2. Çöº´·Â 3. °¡Á·º´·Â 4. °£È£·Â »çÁ¤ 5. ³«»óÀ§Çèµµ Æò°¡µµ±¸ 6. ¿åâÀ§Çèµµ Æò°¡µµ±¸ 7. ½Åü°ËÁø 8. Áø´Ü°Ë»ç 9. Åõ¿©¾à¹° ¥². °£È£°úÁ¤ 1. °£È£¹®Á¦¸ñ·Ï 2. °£È£°úÁ¤ ¥³. Âü°í¹®Çå / ¥°¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   15page   3,000 ¿ø
½Ç½Àº´µ¿ °£È£ È°µ¿ º¸°í¼­ Drainge Hemo-vac

½Ç½Àº´µ¿ °£È£ È°µ¿ º¸°í¼­ Drainge Hemo-vac

½Ç½Àº´µ¿ °£È£ È°µ¿ º¸°í¼­ Drainge Hemo-vac / 1. ÁÖÁ¦ 2. °üÂû »ç·Ê »óȲ ¿ä¾àÁ¤¸® 3. °£È£È°µ¿(¸ñÀû, Á¤ÀÇ, ÀûÀÀÁõ°ú ±Ý±âÁõ, ÀýÂ÷ ¹× ¹æ¹ý, ÀüÈÄ°£È£ ¹× À¯ÀÇ»çÇ× µî) 1) °üÂûÇÑ ³»¿ë 2) ÀÌ·Ð 1. Á¤ÀÇ 2. ¸ñÀû 3. ÀûÀÀÁõ 4. ÀýÂ÷ ¹× ¹æ¹ý 5. °£È£ 6. À¯ÀÇ»çÇ× / 1. ÁÖÁ¦ Drainge Hemo-vac ½Ã½ºÅÛÀº ¼ö¼ú ÈÄ »óó Ä¡À¯ °úÁ¤¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¹è¾× ÀåÄ¡ÀÌ´Ù. ÀÌ¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   8page   3,000 ¿ø
ÇнÀº¸°í¼­ Glucose tolerance(502), Glycosylated hemoglobin(507), C-peptide(319)

ÇнÀº¸°í¼­ Glucose tolerance(502), Glycosylated hemoglobin(507), C-peptide(319)

ÇнÀº¸°í¼­ Glucose tolerance(502), Glycosylated hemoglobin(507), C-peptide(319) / ¥°. Glucose tolerance 1. Glucose tolerance testÀÇ Á¤ÀÇ 2. ½ÃÇà¸ñÀû°ú ÀÇ¹Ì 3. °Ë»ç ½ÃÇà¹æ¹ý 4. ÁÖÀÇ»çÇ× ¥±. Glycosylated hemoglobin 1. Glycosylated hemoglobin°Ë»çÀÇ Á¤ÀÇ 2. ½ÃÇà¸ñÀû°ú ÀÇ¹Ì 3. °Ë»ç ½ÃÇà¹æ¹ý 4. ÁÖÀÇ »çÇ× ¥². C-peptide 1. C-peptideÀÇ Á¤ÀÇ 2. ½ÃÇà¸ñÀû¡¦
·¹Æ÷Æ® > ÀǾຸ°Ç   11page   3,000 ¿ø
ģȯ°æ±¸Á¶Àç Hemcrete ȯ°æģȭ°ÇÃà ¸®Æ÷Æ®

ģȯ°æ±¸Á¶Àç Hemcrete ȯ°æģȭ°ÇÃà ¸®Æ÷Æ®

ģȯ°æ±¸Á¶Àç Hemcrete ȯ°æģȭ°ÇÃà ¸®Æ÷Æ® / 1. ¼­·Ð - ÄÜÅ©¸®Æ®¸¦ ´ëüÇÒ »õ·Î¿î ģȯ°æ±¸Á¶Àç 2. º»·Ð 1) HempcreteÀÇ »ý¾ÖÁÖ±â 2) Hempcrete VS. Concrete 3) HempÀÇ ±¹³»»ý»ê¿¡ ´ëÇÑ ±ÔÁ¦ 3. °á·Ð - ±¹³»»ý»ê ±ÔÁ¦ÀÇ ¿ÏÈ­ ÇÊ¿ä 4. REFERENCE / 1. ¼­·Ð - ÄÜÅ©¸®Æ®¸¦ ´ëüÇÒ »õ·Î¿î ģȯ°æ±¸Á¶Àç ÃÖ±Ù Áö±¸ ȯ°æ ¹®Á¦¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ °ÇÃà »ê¾÷¿¡¼­µµ Áö¼Ó °¡¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   6page   3,000 ¿ø
ISSUES OF HEMTs, ¹ÝµµÃ¼

ISSUES OF HEMTs, ¹ÝµµÃ¼

ISSUES OF HEMTs, ¹ÝµµÃ¼ / 1.GaAs pHEMTs 2.InP HEMTs / 1.GaAs pHEMTs GaAs pHEMTs(ÁÖ·Î GaAs ±â¹ÝÀÇ Æí±ØÇü °íÀüÀÚ À̵¿µµ Æ®·£Áö½ºÅÍ)´Â ÀüÀÚ±â±â¿Í Åë½Å ºÐ¾ß¿¡¼­ Æø³Ð°Ô »ç¿ëµÇ´Â Áß¿äÇÑ ¹ÝµµÃ¼ ¼ÒÀÚ´Ù. ÀÌ ¼ÒÀÚ´Â GaAs(°¥·ý ºñ¼Ò) ±âÆÇ À§¿¡ »ý±ä °íÀüµµ¼º ÀüÀÚÃþ°ú ´Ù¾çÇÑ Æ¯¼ºÀ» °¡Áø ÃþÀ¸·Î ±¸¼ºµÇ¾î ÀÖ¾î, °í¼Ó ¹× °íÁÖÆÄ ÀÀ¿ë ºÐ¾ß¿¡¼­ ¶Ù¾î³­ ¼º´ÉÀ» ¹ßÈÖÇÑ´Ù. GaAs pH¡¦
·¹Æ÷Æ® > °øÇбâ¼ú   2page   3,000 ¿ø
¹Ì»ý¹° ¹× »ý¹°°øÇÐ ±âÃʽÇÇè ·¹Æ÷Æ®(Influenza virus culture and titration by hemagglutination assay)

¹Ì»ý¹° ¹× »ý¹°°øÇÐ ±âÃʽÇÇè ·¹Æ÷Æ®(Influenza virus culture and titration by hemagglutination assay)

¡¥ay´Â ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½ºÀÇ ¹è¾ç ¹× Ç÷±¸ ÀÀÁý ¹ÝÀÀ(Hemagglutination Assay, HA)À» ÅëÇÑ ¹ÙÀÌ·¯½ºÀÇ ³óµµ ÃøÁ¤ ¹æ¹ýÀ» ¼³¸íÇÏ´Â Áß¿äÇÑ ½ÇÇèÀû Á¢±Ù ¹æ½ÄÀÌ´Ù. ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º´Â ¼¼°èÀûÀ¸·Î °¨¿°º´À» ÀÏÀ¸Å°¸ç °ø°ø º¸°Ç¿¡ Å« ¿µÇâÀ» ¹ÌÄ£´Ù. µû¶ó¼­ ÀÌ ¹ÙÀÌ·¯½º¸¦ ¿¬±¸ÇÏ´Â °ÍÀº Áß¿äÇÑ ÀÛ¾÷ÀÌ´Ù. ½ÇÇèÀÇ Ã¹ ´Ü°è´Â ÀÎÇ÷翣ÀÚ ¹ÙÀÌ·¯½º¸¦ ÀûÀýÇÑ ¼÷ÁÖ ¼¼Æ÷¿¡¼­ ¹è¾çÇÏ´Â °ÍÀÌ´Ù¡¦
½ÇÇè°úÁ¦ > »ý¹°ÀÇÇÐ   4page   3,000 ¿ø




ȸ»ç¼Ò°³ | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ | °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 ¤Ó ±¤ÁÖ±¤¿ª½Ã ±¤»ê±¸ ¹«Áø´ë·Î 326-6, 201È£ | äÈñÁØ | Åë½Å : ±¤»ê0561È£
Copyright¨Ï ¿Ã·¹¼ÒÇÁÆ® All rights reserved | Tel.070-8744-9518
ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æħ ¤Ó °í°´¼¾ÅÍ ¤Ó olle@olleSoft.co.kr
¿Ã·¹¼ÒÇÁÆ® | »ç¾÷ÀÚ : 408-04-51642 | Tel.070-8744-9518